,
Ma Ke,
Wang Jianxiu,
Wang Dequan,
Shi Cunwei,
Liu Jinfeng,
Liu Haipeng,
Song Tao,
Zhang Baojuan,
Lin Xuewu,
Zhou Huacheng,
Wan Chunfu,
Cao Hanzhong,
Shu Ya,
Fan Xiaochong,
Liu Yanqing*
Background: Chronic cancer-related pain can seriously damage physical and mental health of cancer patients. Eliminating cancer pain is basic right of cancer patients, controlling and eliminating cancer pain is the responsibility of medical staff. Objective: To further enhance the diagnosis and treatment capabilities for chronic cancer-related pain management, the Chinese Clinical Guideline for Chronic Cancer-Related Pain convened an expert panel to develop the guideline. Main ideas: Based on high quality evidence of medical researches on the diagnosis and treatment of chronic cancer-related pain published domestically and internationally in the past 10 years, the expert group has formed recommendations for common treatment methods through rigorous argumentation and expert voting, to provide references for standardized diagnosis and treatment of chronic cancer-related pain. This guideline adopts GRADE methodology to evaluate the level of evidence and strength of recommendation for the treatments of chronic cancer-related pain. This guideline gives treatment recommendations for different types of chronic cancer-related pain in International Classification of Diseases-11, as well as for breakthrough cancer pain. Conclusion: Although there are many treatments to relieve chronic cancer-related pain, it is still a global medical challenge. According to the characteristics of cancer-related pain, stepped and personalized treatment is the key to relieve pain.
| Published in | International Journal of Pain Research (Volume 1, Issue 1) |
| DOI | 10.11648/j.ijpr.20250101.12 |
| Page(s) | 10-33 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2025. Published by Science Publishing Group |
Chronic Cancer-related Pain, Cancer Pain, Guideline
| [1] | Zylla D, Steele G, Gupta P. A systematic review of the impact of pain on overall survival in patients with cancer [J]. Support Care Cancer, 2017, 25(5): 1687-1698. |
| [2] | Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. introduction GRADE evidence profiles and summary of findings tables [J]. J Clin Epidemiol, 2011, 64(4): 383394. |
| [3] | Balshem H, Helfand M, Schünemann HJ, et al. GRADE guidelines: 3. rating the quality of evidence [J]. J Clin Epidemiol, 2011, 64(4): 401406. |
| [4] | Jaeschke R, Guyatt GH, Dellinger P, et al. Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive[J]. BMJ, 2008, 337: a744. |
| [5] |
Li XM, Yuan WQ, Cao BX, et al. Chronic cancer-related pain [J]. Chinese Journal of Pain Medicine, 2021, 27(3): 161-165.
https://doi.org/10.3969/j.issn.1006-9852.2021.03.001. (In Chinese). |
| [6] | Bennett MI, Kaasa S, Barke A, et al; IASP Taskforce for the Classification of Chronic Pain. The IASP classification of chronic pain for ICD-11: chronic cancer-related pain [J]. Pain, 2019, 160(1): 38-44. |
| [7] | Scarborough BM, Smith CB. Optimal pain management for patients with cancer in the modern era [J]. CA Cancer J Clin, 2018, 68(3): 182-196. |
| [8] | Brozović G, Lesar N, Janev D, et al. CANCER PAIN AND THERAPY [J]. Acta Clin Croat, 2022, 61(Suppl 2): 103-108. |
| [9] | Mardelle U, Bretaud N, Daher C, et al. From pain to tumor immunity: influence of peripheral sensory neurons in cancer [J]. Front Immunol, 2024, 15: 1335387. |
| [10] | Zheng XQ, Wu YH, Huang JF, et al. Neurophysiological mechanisms of cancer-induced bone pain [J]. J Adv Res, 2021, 35: 117-127. |
| [11] | Yoon SY, Oh J. Neuropathic cancer pain: prevalence, pathophysiology, and management [J]. Korean J Intern Med, 2018, 33(6): 1058-1069. |
| [12] | Atherton MA, Park S, Horan NL, et al. Sympathetic modulation of tumor necrosis factor alpha-induced nociception in the presence of oral squamous cell carcinoma [J]. Pain, 2023, 164(1): 27-42. |
| [13] |
Pain Physician Branch of Chinese Medical Doctor Association, Pain Medicine Branch of Chinese Medical Association, National Pain Medicine Quality Control Center, et al. Chinese expert consensus on cancer-related pain assessment (2023 version) [J]. Chinese Journal of Pain Medicine, 2023, 29(12): 881-886.
https://doi.org/10.3969/j.issn.1006-9852.2023.12.001 (In Chinese). |
| [14] | Kumar SK, Callander NS, Adekola K, et al. Multiple Myeloma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology [J]. J Natl Compr Canc Netw, 2023, 21(12): 1281-1301. |
| [15] |
National Comprehensive Cancer Network. “NCCN Guidelines”. Available from:
https://www.nccn.org/guidelines/guidelines-detail?category=3&id=1413 [Accessed 15 July 2025]. |
| [16] | Vargas-Schaffer G. Is the WHO analgesic ladder still valid? Twenty-four years of experience[J]. Can Fam Physician, 2010, 56(6): 514-7. |
| [17] | Su WC, Chuang CH, Chen FM, et al. Effects of Good Pain Management (GPM) ward program on patterns of care and pain control in patients with cancer pain in Taiwan [J]. Support Care Cancer, 2021, 29(4): 1903-1911. |
| [18] | Henson LA, Maddocks M, Evans C, et al. Palliative care and the management of common distressing symptoms in advanced cancer: pain, breathlessness, nausea and vomiting, and gatigue [J]. J Clinc Oncolo, 2020, 38(9): 905-914. |
| [19] |
Feng D, Chen P, Liu X, et al. Systematic evaluation of pain management guidelines in hospice care [J]. Chinese Nursing Research, 2021, 35(1): 48-54.
https://doi.org/10.12102/j.issn.1009-6493.2021.01.009 (In Chinese). |
| [20] | Jara C, Del Barco S, Grávalos C, et al. SEOM clinical guideline for treatment of cancer pain (2017) [J]. Clin Transl Oncol, 2018, 20(1): 97-107. |
| [21] | Yamanaka M. A Concept Analysis of Self-Management of Cancer Pain [J]. Asia Pac J Oncol Nurs, 2018, 5(3): 254-261. |
| [22] | González-Martín AM, Aguilera-García I, Castellote-Caballero Y, et al. Effectiveness of Therapeutic Education in Patients with Cancer Pain: Systematic Review and Meta-Analysis[J]. Cancers (Basel), 2023, 15(16): 4123. |
| [23] | Edwards Z, Ziegler L, Craigs C, et al. Pharmacist educational interventions for cancer pain management: a systematic review and meta-analysis [J]. Int J Pharm Pract, 2019, 27(4): 336-345. |
| [24] | Makhlouf SM, Pini S, Ahmed S, et al. Managing Pain in People with Cancer-a Systematic Review of the Attitudes and Knowledge of Professionals, Patients, Caregivers and Public[J]. J Cancer Educ, 2020, 35(2): 214-240. |
| [25] | Zhang J, Chan DNS, Liu X, et al. Effects of self-management interventions for cancer patients with pain: A systematic review of randomized controlled trials [J]. J Clin Nurs, 2023, 32(17-18): 5652-5667. |
| [26] | Hernandez Silva E, Lawler S, Langbecker D. The effectiveness of mHealth for self-management in improving pain, psychological distress, fatigue, and sleep in cancer survivors: a systematic review [J]. J Cancer Surviv, 2019, 13(1): 97-107. |
| [27] | You E. Nontraditional and Home-Based Self-management Interventions in Cancer Patients With Pain: A Mixed-Method Systematic Review [J]. Holist Nurs Pract, 2020, 34(3): 138-149. |
| [28] | Schmidt-Hansen M, Bennett MI, Arnold S, et al. Oxycodone for cancer-related pain [J]. Cochrane Database Syst Rev, 2022, 6(6): CD003870. |
| [29] | Rodríguez MJ, Contreras D, Gálvez R, et al. Double-blind evaluation of short-term analgesic efficacy of orally administered dexketoprofen trometamol and ketorolac in bone cancer pain[J]. Pain, 2003, 104(1-2): 103-10. |
| [30] | Wiffen PJ, Wee B, Moore RA. Oral morphine for cancer pain [J]. Cochrane Database Syst Rev, 2016, 4(4): CD003868. |
| [31] | Wang DD, Ma TT, Zhu HD, et al. Transdermal fentanyl for cancer pain: Trial sequential analysis of 3406 patients from 35 randomized controlled trials [J]. J Cancer Res Ther, 2018, 14(Supplement): S14-S21. |
| [32] | Reis PS, Kraychete DC, Pedreira EM, et al. Transdermal Opioids and the Quality of Life of the Cancer Patient: A Systematic Literature Review [J]. Ann Pharmacother, 2024, 10600280241247363. |
| [33] | Caraceni A, Hanks G, Kaasa S, et al; European Palliative Care Research Collaborative (EPCRC); European Association for Palliative Care (EAPC). Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC [J]. Lancet Oncol, 2012, 13(2): e58-68. |
| [34] |
Professional Committee of Cancer Rehabilitation and Palliative Care, Hubei Anti-Cancer Association. Guideline for rational clinical use of fentanyl transdermal patches [J]. Herald of Medicine, 2021, 40(11): 1463-1474.
https://doi.org/10.3870/j.issn.1004-0781.2021.11.001 (In Chinese). |
| [35] | Huerta MÁ, de la Nava J, Artacho-Cordón A, et al. Efficacy and Security of Tetrodotoxin in the Treatment of Cancer-Related Pain: Systematic Review and Meta-Analysis [J]. Mar Drugs, 2023, 21(5): 316. |
| [36] | Hagen NA, Cantin L, Constant J, et al. Tetrodotoxin for Moderate to Severe Cancer-Related Pain: A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design Trial [J]. Pain Res Manag, 2017, 2017: 7212713. |
| [37] | Lippi L, de Sire A, Turco A, et al. Botulinum Toxin for Pain Relief in Cancer Patients: A Systematic Review of Randomized Controlled Trials [J]. Toxins (Basel), 2024, 16(3): 153. |
| [38] | Li S, Peng S, Chen F, et al. The application and therapeutic effect of botulinum toxin type a (BTX-A) in the treatment of patients with pain after cancer treatment: a systematic review and meta-analysis [J]. Int J Surg, 2024, 110(2): 1215-1223. |
| [39] | Xu JM, Song ST, Feng FY, Huang FL, Yang Y, Xie GR, Xu LG, Zhang CZ, Bruno M, Paradiso A. Cobrotoxin-containing analgesic compound to treat chronic moderate to severe cancer pain: results from a randomized, double-blind, cross-over study and from an open-label study [J]. Oncol Rep. 2006 Nov; 16(5): 1077-84. |
| [40] |
Yang HP, Huai ZR, Zhu TX. Efficacy observation of cobratide enteric-coated capsules in treating moderate to severe cancer pain in advanced stage [J]. Journal of Snakes, 2001, 13(2): 4-5.
https://doi.org/10.3969/j.issn.1001-5639.2001.02.002 (In Chinese). |
| [41] | Nagaoka H, Momo K, Hamano J, et al. Effects of an Indomethacin Oral Spray on Pain Due to Oral Mucositis in Cancer Patients Treated With Radiotherapy and Chemotherapy: A Double-Blind, Randomized, Placebo-Controlled Trial (JORTC-PAL04) [J]. J Pain Symptom Manage, 2021, 62(3): 537-544. |
| [42] | Huang R, Jiang L, Cao Y, et al. Comparative Efficacy of Therapeutics for Chronic Cancer Pain: A Bayesian Network Meta-Analysis [J]. J Clin Oncol, 2019, 37(20): 1742-1752. |
| [43] | Christoforou J, Karasneh J, Manfredi M, et al. World Workshop on Oral Medicine VII: Non-opioid pain management of head and neck chemo/radiation-induced mucositis: A systematic review [J]. Oral Dis, 2019, 25 Suppl 1: 182-192. |
| [44] | Wiffen PJ, Derry S, Moore RA. Tramadol with or without paracetamol (acetaminophen) for cancer pain [J]. Cochrane Database Syst Rev, 2017, 5(5): CD012508. |
| [45] | Shinkai M, Katsumata N, Kawai S, et al. Phase III study of bilayer sustained-release tramadol tablets in patients with cancer pain: a double-blind parallel-group, non-inferiority study with immediate-release tramadol capsules as an active comparator [J]. Support Care Cancer, 2023, 32(1): 69. |
| [46] | Straube C, Derry S, Jackson KC, et al. Codeine, alone and with paracetamol (acetaminophen), for cancer pain [J]. Cochrane Database Syst Rev, 2014, 2014(9): CD006601. |
| [47] | Leppert W, Nosek K. Comparison of the Quality of Life of Cancer Patients with Pain Treated with Oral Controlled-Release Morphine and Oxycodone and Transdermal Buprenorphine and Fentanyl [J]. Curr Pharm Des, 2019, 25(30): 3216-3224. |
| [48] | Chen LJ, Tang R, Xiang F, et al. Systematic evaluation of fentanyl transdermal patches versus morphine sustained-release tablets for moderate to severe cancer pain [J]. China Pharmaceuticals, 2015(18): 51-54, 55. (In Chinese). |
| [49] |
Li Q, Xu JQ, Chen B. Meta-analysis comparing analgesic effects of oxycodone and morphine in patients with moderate to advanced cancer pain [J]. Practical Pharmacy and Clinical Remedies, 2016, 19(3): 318-321.
https://doi.org/10.14053/j.cnki.ppcr.201603016 (In Chinese). |
| [50] | Hou XB, Chen DD, Cheng TF, et al. Meta-analysis of efficacy and safety of sustained release oxycodone hydrochloride rectal administration for moderate to severe pain [J]. PLoS One, 2022, 17(6): e0266754. |
| [51] | Schmidt-Hansen M, Bennett MI, Arnold S, et al. Efficacy, tolerability and acceptability of oxycodone for cancer-related pain in adults: an updated Cochrane systematic review [J]. BMJ Support Palliat Care, 2018, 8(2): 117-128. |
| [52] |
Zhang XY, Li PB, Yang J, et al. Systematic evaluation of safety and efficacy of oxycodone hydrochloride controlled-release tablets for moderate to severe cancer pain [J]. Chinese Journal of Hospital Pharmacy, 2024, 44(8): 916-924.
https://doi.org/10.13286/j.1001-5213.2024.08.09 (In Chinese). |
| [53] | Xi Y. Systematic evaluation of fentanyl transdermal patch versus morphine for moderate to severe cancer pain [J]. Journal of Medicine Frontiers, 2017, 7(24): 147-148. (In Chinese). |
| [54] | Li Y, Ma J, Lu G, et al. Hydromorphone for cancer pain [J]. Cochrane Database Syst Rev, 2021, 8(8): CD011108. |
| [55] | Zeng X, Zhu J, Li J, et al. Patient Controlled Subcutaneous Analgesia of Hydromorphone Versus Morphine to Treat Moderate and Severe Cancer Pain: A Randomized Double-Blind Controlled Trial [J]. J Pain Symptom Manage, 2024, 67(1): 50-58. |
| [56] | Ma K, Jin Y, Wang L, et al. Intrathecal delivery of hydromorphone vs morphine for refractory cancer pain: a multicenter, randomized, single-blind, controlled noninferiority trial [J]. Pain, 2020, 161(11): 2502-2510. |
| [57] |
Zeng YD, Xi SL, Tang HQ. Efficacy and safety of hydromorphone patient-controlled analgesia for cancer pain: A meta-analysis [J]. Chinese Journal of Painology, 2022, 18(5): 670-677.
https://doi.org/10.3760/cma.j.cn101658-20221018-00158 (In Chinese). |
| [58] | Schmidt-Hansen M, Bromham N, Taubert M, et al. Buprenorphine for treating cancer pain [J]. Cochrane Database Syst Rev, 2015, 2015(3): CD009596. |
| [59] | Nicholson AB, Watson GR, Derry S, et al. Methadone for cancer pain [J]. Cochrane Database Syst Rev, 2017, 2(2): CD003971. |
| [60] | Imkamp MSV, Theunissen M, Viechtbauer W, et al. Shifting views on cancer pain management: a systematic review and network meta-analysis [J]. J Pain Symptom Manage, 2024, S0885-3924(24)00790-5. |
| [61] | Mercadante S, Bruera E. Methadone as a First-Line Opioid in Cancer Pain Management: A Systematic Review [J]. J Pain Symptom Manage, 2018, 55(3): 998-1003. |
| [62] | Haumann J, Geurts JW, van Kuijk SM, et al. Methadone is superior to fentanyl in treating neuropathic pain in patients with head-and-neck cancer [J]. Eur J Cancer, 2016, 65: 121-9. |
| [63] | Kouri M, Rekatsina M, Vadalouca A, et al. Pharmacological Management of Neuropathic Pain after Radiotherapy in Head and Neck Cancer Patients: A Systematic Review [J]. J Clin Med, 2022, 11(16): 4877. |
| [64] | Haumann J, van Kuijk SMJ, Geurts JW, et al. Methadone versus Fentanyl in Patients with Radiation-Induced Nociceptive Pain with Head and Neck Cancer: A Randomized Controlled Noninferiority Trial [J]. Pain Pract, 2018, 18(3): 331-340. |
| [65] |
Zhao DB. Systematic evaluation of dezocine injection for persistent pain in cancer patients [J]. Northern Pharmacy, 2017, 14(12): 187.
https://doi.org/10.3969/j.issn.1672-8351.2017.12.153 (In Chinese). |
| [66] |
Dong WS, Li J, Chen HJ, et al. Systematic evaluation of dezocine injection for persistent pain in cancer patients [J]. Chinese Journal of Pain Medicine, 2016, 22(2): 123-127.
https://doi.org/10.3969/j.issn.1006-9852.2016.02.009 (In Chinese). |
| [67] | Dupoiron D, Stachowiak A, Loewenstein O, et al. Long-term efficacy and safety of oxycodone-naloxone prolonged-release formulation (up to 180/90 mg daily) - results of the open-label extension phase of a phase III multicenter, multiple-dose, randomized, controlled study [J]. Eur J Pain, 2017, 21(9): 1485-1494. |
| [68] | Ahmedzai SH, Leppert W, Janecki M, et al. Long-term safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe chronic cancer pain [J]. Support Care Cancer, 2015, 23(3): 823-30. |
| [69] | Lee KH, Kim TW, Kang JH, et al. Efficacy and safety of controlled-release oxycodone/naloxone versus controlled-release oxycodone in Korean patients with cancer-related pain: a randomized controlled trial [J]. Chin J Cancer, 2017, 36(1): 74. |
| [70] | Koopmans G, Simpson K, De Andrés J, et al. Fixed ratio (2: 1) prolonged-release oxycodone/naloxone combination improves bowel function in patients with moderate-to-severe pain and opioid-induced constipation refractory to at least two classes of laxatives [J]. Curr Med Res Opin, 2014, 30(11): 2389-96. |
| [71] |
Li L, Liu Y, Qian WJ. Clinical efficacy and safety of oxycodone controlled-release tablets versus acetaminophen-oxycodone for moderate to severe pain: A meta-analysis [J]. Shenzhen Journal of Integrated Traditional Chinese and Western Medicine, 2015, 25(24): 9-11.
https://doi.org/10.16458/j.cnki.1007-0893.2015.24.005 (In Chinese). |
| [72] | Zhang ZL, Wu ZY, Liu FY, et al. Tetrandrine alleviates oxaliplatin-induced mechanical allodynia via modulation of inflammation-related genes [J]. Front Mol Neurosci, 2024, 17: 1333842. |
| [73] |
Fan YF, Yu ZP, Cui XY. Therapeutic efficacy of spleen polypeptide injection combined with morphine sustained-release tablets for moderate to severe cancer pain [J]. Chinese Journal of Practical Medicine, 2015(19): 80-81.
https://doi.org/10.3760/cma.j.issn.1674-4756.2015.19.042 (In Chinese). |
| [74] | van den Beuken-van Everdingen MH, de Graeff A, Jongen JL, et al; national guideline working group “Diagnosis treatment of cancer pain”. Pharmacological Treatment of Pain in Cancer Patients: The Role of Adjuvant Analgesics, a Systematic Review [J]. Pain Pract, 2017, 17(3): 409-419. |
| [75] | Gül ŞK, Tepetam H, Gül HL. Duloxetine and pregabalin in neuropathic pain of lung cancer patients [J]. Brain Behav, 2020, 10(3): e01527. |
| [76] | Salehifar E, Janbabaei G, Hendouei N, et al. Comparison of the Efficacy and Safety of Pregabalin and Duloxetine in Taxane-Induced Sensory Neuropathy: A Randomized Controlled Trial [J]. Clin Drug Investig, 2020, 40(3): 249-257. |
| [77] | Lefebvre T, Tack L, Lycke M, et al. Effectiveness of Adjunctive Analgesics in Head and Neck Cancer Patients Receiving Curative (Chemo-) Radiotherapy: A Systematic Review [J]. Pain Med, 2021, 22(1): 152-164. |
| [78] | Farshchian N, Alavi A, Heydarheydari S, et al. Comparative study of the effects of venlafaxine and duloxetine on chemotherapy-induced peripheral neuropathy [J]. Cancer Chemother Pharmacol, 2018, 82(5): 787-793. |
| [79] |
Zhang XL, Yuan HY, Zhang XH. Meta-analysis of gabapentin for diabetic peripheral neuropathic pain [J]. Drug Evaluation Research, 2015, 38(5): 557‑562.
https://doi.org/10.7501/j.issn.1674‑6376.2015.05.020 (In Chinese). |
| [80] | D'Souza RS, Alvarez GAM, Dombovy-Johnson M, et al. Evidence-Based Treatment of Pain in Chemotherapy-Induced Peripheral Neuropathy [J]. Curr Pain Headache Rep, 2023, 27(5): 99-116. |
| [81] | Wang M, Pei Z, Molassiotis A. Recent advances in managing chemotherapy-induced peripheral neuropathy: A systematic review [J]. Eur J Oncol Nurs, 2022, 58: 102134. |
| [82] | Lee JT, Sanderson CR, Xuan W, et al. Lidocaine for Cancer Pain in Adults: A Systematic Review and Meta-Analysis [J]. J Palliat Med, 2019, 22(3): 326-334. |
| [83] | Cabezón-Gutiérrez L, Custodio-Cabello S, Palka-Kotlowska M, et al. High-Dose 8% Capsaicin Patch in Treatment of Chemotherapy-Induced Peripheral Neuropathy. A Systematic Review [J]. J Pain Symptom Manage, 2020, 60(5): 1047-1054. e1. |
| [84] | Larsson IM, Ahm Sørensen J, Bille C. The Post-mastectomy Pain Syndrome-A Systematic Review of the Treatment Modalities [J]. Breast J, 2017, 23(3): 338-343. |
| [85] | Jiao J, Fan J, Zhang Y, et al. Efficacy and Safety of Ketamine to Treat Cancer Pain in Adult Patients: A Systematic Review [J]. J Pain Symptom Manage, 2024, 67(3): e185-e210. |
| [86] | Kim HJ, Kim YS, Park SH. Opioid rotation versus combination for cancer patients with chronic uncontrolled pain: a randomized study [J]. BMC Palliat Care, 2015, 14: 41. |
| [87] | Liang J, Chen L, Yang S, et al. A 12-hour rapid titration method for cancer pain: a randomized, controlled, open-label study [J]. Ann Palliat Med, 2021, 10(1): 88-96. |
| [88] | Zhang YY, Zhou R, Gu WJ. Efficacy and Safety of Methylnaltrexone for the Treatment of Opioid-Induced Constipation: A Meta-analysis of Randomized Controlled Trials. Pain Ther, 2021, 10(1): 165-179. |
| [89] | Marín-Conde F, Castellanos-Cosano L, Pachón-Ibañez J, et al. Photobiomodulation with low-level laser therapy reduces oral mucositis caused by head and neck radio-chemotherapy: prospective randomized controlled trial [J]. Int J Oral Maxillofac Surg, 2019, 48(7): 917-923. |
| [90] | De Pauli Paglioni M, Alves CGB, Fontes EK, et al. Is photobiomodulation therapy effective in reducing pain caused by toxicities related to head and neck cancer treatment? A systematic review [J]. Support Care Cancer, 2019, 27(11): 4043-4054. |
| [91] | Amadori F, Bardellini E, Conti G, et al. Low-level laser therapy for treatment of chemotherapy-induced oral mucositis in childhood: a randomized double-blind controlled study [J]. Lasers Med Sci, 2016, 31(6): 1231-1236. |
| [92] | He M, Zhang B, Shen N, et al. A systematic review and meta-analysis of the effect of low-level laser therapy (LLLT) on chemotherapy-induced oral mucositis in pediatric and young patients [J]. Eur J Pediatr, 2018, 177(1): 7-17. |
| [93] | Smoot B, Chiavola-Larson L, Lee J, et al. Effect of low-level laser therapy on pain and swelling in women with breast cancer-related lymphedema: a systematic review and meta-analysis [J]. J Cancer Surviv, 2015, 9(2): 287-304. |
| [94] | He L, Tan K, Lin X, et al. Multicenter, randomized, double-blind, controlled trial of transcutaneous electrical nerve stimulation for pancreatic cancer related pain [J]. Medicine (Baltimore), 2021, 100(5): e23748. |
| [95] | Gewandter JS, Culakova E, Davis JN, et al. Wireless Transcutaneous Electrical Nerve Stimulation (TENS) for Chronic Chemotherapy-Induced Peripheral Neuropathy (CIPN): A Proof-of-Concept Randomized Clinical Trial [J]. J Pain, 2024, 25(5): 104431. |
| [96] | Püsküllüoğlu M, Tomaszewski KA, Grela-Wojewoda A, et al. Effects of Transcutaneous Electrical Nerve Stimulation on Pain and Chemotherapy-Induced Peripheral Neuropathy in Cancer Patients: A Systematic Review [J]. Medicina (Kaunas), 2022, 58(2): 284. |
| [97] | Kashyap K, Bhatnagar S. Evidence for the Efficacy of Scrambler Therapy for Cancer Pain: A Systematic Review [J]. Pain Physician, 2020, 23(4): 349-364. |
| [98] | Capetti B, Conti L, Marzorati C, et al. The Application of tDCS to Treat Pain and Psychocognitive Symptoms in Cancer Patients: A Scoping Review [J]. Neural Plast, 2024, 2024: 6344925. |
| [99] | Yao C, Cheng Y, Zhu Q, et al. Clinical Evidence for the Effects of Manual Therapy on Cancer Pain: A Systematic Review and Meta-Analysis [J]. Evid Based Complement Alternat Med, 2021, 2021: 6678184. |
| [100] | Pattanshetty RB, Patil SN. Role of Manual Therapy for Neck Pain and Quality of Life in Head and Neck Cancer Survivors: A Systematic Review [J]. Indian J Palliat Care, 2022, 28(1): 99-112. |
| [101] | Nakagawa N, Yamamoto S, Hanai A, et al. Exercise intervention for the management of chemotherapy-induced peripheral neuropathy: a systematic review and network meta-analysis [J]. Front Neurol, 2024, 15: 1346099. |
| [102] | Dhawan S, Andrews R, Kumar L, et al. A Randomized Controlled Trial to Assess the Effectiveness of Muscle Strengthening and Balancing Exercises on Chemotherapy-Induced Peripheral Neuropathic Pain and Quality of Life Among Cancer Patients [J]. Cancer Nurs, 2020, 43(4): 269-280. |
| [103] | Buwenge M, Macchia G, Arcelli A, et al. Stereotactic radiotherapy of pancreatic cancer: a systematic review on pain relief [J]. J Pain Res, 2018, 11: 2169-2178. |
| [104] | Guninski RS, Cuccia F, Alongi F, et al. Efficacy and safety of SBRT for spine metastases: A systematic review and meta-analysis for preparation of an ESTRO practice guideline [J]. Radiother Oncol, 2024, 190: 109969. |
| [105] | Wang Z, Li L, Yang X, et al. Efficacy and safety of stereotactic body radiotherapy for painful bone metastases: Evidence from randomized controlled trials [J]. Front Oncol, 2022, 12: 979201. |
| [106] | Tariq UB, Naseer Khan MA, Barkha FNU, et al. Comparative Analysis of Stereotactic Radiation Therapy and Conventional Radiation Therapy in Cancer Pain Control: A Systematic Review and Meta-Analysis [J]. Clin Oncol (R Coll Radiol), 2024, 36(7): 452-462. |
| [107] | Jong JM, Oprea-Lager DE, Hooft L, et al. Radiopharmaceuticals for Palliation of Bone Pain in Patients with Castration-resistant Prostate Cancer Metastatic to Bone: A Systematic Review [J]. Eur Urol, 2016, 70(3): 416-26. |
| [108] | Agarwal KK, Singla S, Arora G, et al. (177)Lu-EDTMP for palliation of pain from bone metastases in patients with prostate and breast cancer: a phase II study [J]. Eur J Nucl Med Mol Imaging, 2015, 42(1): 79-88. |
| [109] | Han X, Huang R, Meng T, et al. The Roles of Magnetic Resonance-Guided Focused Ultrasound in Pain Relief in Patients With Bone Metastases: A Systemic Review and Meta-Analysis [J]. Front Oncol, 2021, 11: 617295. |
| [110] |
Cancer Pain Expert Group of Beijing Pain Treatment Quality Control and Improvement Center. Expert consensus on rational use of Chinese patent medicines in standardized cancer pain management [J]. Chinese Journal of Pain Medicine, 2021, 2021, 27(1): 9-17.
https://doi.org/10.3969/j.issn.1006-9852.2021.01.003 (In Chinese). |
| [111] | Huang YX, Guo YM, Sang XX, et al. Systematic review of Compound Kushen Injection for cancer pain treatment [J]. Chinese Journal of Experimental Traditional Medical Formulae, 2016, 22(2): 172-179. |
| [112] | Yanju B, Yang L, Hua B, et al. A systematic review and meta-analysis on the use of Traditional Chinese Medicine compound kushen injection for bone cancer pain [J]. Support Care Cancer, 2014, 22(3): 825-836. |
| [113] |
Xu J, Qian SS, Chen YG, et al. Systematic review and Meta-analysis of the efficacy and safety of Cinobufacini injection for cancer pain [J]. China Journal of Chinese Materia Medica, 2019, 44(12): 2627-2636.
https://doi.org/10.19540/j.cnki.cjcmm.20190304.003 (In Chinese). |
| [114] | Ye X, Lu D, Chen X, et al. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Shuangbai San for Treating Primary Liver Cancer Patients With Cancer Pain [J]. J Pain Symptom Manage, 2016, 51(6): 979-86. |
| [115] |
Wang ZN, Fan YD, Xing YM, et al. Meta-analysis of clinical efficacy and safety of external treatments in traditional Chinese medicine for cancer pain [J]. Journal of Oncology in Chinese Medicine, 2022, 4(2): 74-81.
https://doi.org/10.19811/j.cnki.ISSN2096-6628.2022.03.013 (In Chinese). |
| [116] |
Luo YH, Liu Q, Jin RY, et al. Overview of systematic reviews of acupuncture for cancer pain [J]. Chinese Manipulation and Rehabilitation Medicine, 2022, 13(9): 40-45.
https://doi.org/10.19787/j.issn.1008-1879.2022.09.012 (In Chinese). |
| [117] |
Liu YF, Lai BY, An T, et al. Systematic review and Meta-analysis of acupuncture for chemotherapy-induced peripheral neuropathy [J]. Shanghai Journal of Acupuncture and Moxibustion, 2021, 40(4): 511-520.
https://doi.org/10.13460/j.issn.1005-0957.2021.04.0511 (In Chinese). |
| [118] | Ge L, Wang Q, He Y, et al; International Trustworthy traditional Chinese Medicine Recommendations (TCM Recs) Working Group. Acupuncture for cancer pain: an evidence-based clinical practice guideline [J]. Chin Med, 2022, 17(1): 8. |
| [119] | Chiu HY, Hsieh YJ, Tsai PS. Systematic review and meta-analysis of acupuncture to reduce cancer-related pain. Eur J Cancer Care (Engl), 2017, 26(2). |
| [120] | Faria M, Teixeira M, Pinto MJ, et al. Efficacy of acupuncture on cancer pain: A systematic review and meta-an [J] alysis. J Integr Med, 2024, 22(3): 235-244. |
| [121] | Abe H, Inoue R, Tsuchida R, et al. Efficacy of treatments for pain and numbness in cancer survivors: a systematic review and meta-analysis [J]. Ann Palliat Med, 2022, 11(12): 3674-3696. |
| [122] | He Y, Guo X, May BH, et al. Clinical Evidence for Association of Acupuncture and Acupressure With Improved Cancer Pain: A Systematic Review and Meta-Analysis [J]. JAMA Oncol, 2020, 6(2): 271-278. |
| [123] | Yan Z, MuRong Z, Huo B, et al. Acupuncture as a Complementary Therapy for Cancer-Induced Bone Pain: A Systematic Review and Meta-Analysis [J]. Front Pain Res (Lausanne), 2022, 3: 925013. |
| [124] | Chien TJ, Liu CY, Fang CJ, et al. The Efficacy of Acupuncture in Chemotherapy-Induced Peripheral Neuropathy: Systematic Review and Meta-Analysis [J]. Integr Cancer Ther, 2019, 18: 1534735419886662. |
| [125] | Xu Z, Wang X, Wu Y, et al. The effectiveness and safety of acupuncture for chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis [J]. Front Neurol, 2022, 13: 963358. |
| [126] | Zhang J, Wu W, Ren Y, et al. Electroacupuncture for the treatment of cancer pain: a systematic review and meta-analysis of randomized clinical trials [J]. Front Pain Res (Lausanne), 2023, 4: 1186506. |
| [127] |
Zhang CY, Sun LY, Liu X, et al. Efficacy and safety of body acupuncture for cancer pain: A Meta-analysis [J]. Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology, 2023, 25(5): 1538-1547.
https://doi.org/10.11842/wst.20220914002 (In Chinese). |
| [128] | Zhou J, Liang Y, Chen Q, et al. Meta-analysis of randomized controlled trials on acupoint injection therapy for cancer pain [J]. Journal of Zhejiang Chinese Medical University, 2014(7): 927-932. (In Chinese). |
| [129] | Yang Y, Wen J, Hong J. The Effects of Auricular Therapy for Cancer Pain: A Systematic Review and Meta-Analysis [J]. Evid Based Complement Alternat Med, 2020, 2020: 1618767. |
| [130] |
Li WF, Sun SB, Ding PP, et al. Meta-analysis of the efficacy of auricular acupressure for cancer pain [J]. Chinese Evidence-Based Nursing, 2021, 7(15): 2007-2012.
https://doi.org/10.12102/j.issn.2095-8668.2021.15.003 (In Chinese). |
| [131] |
Lee SH, Kim JY, Yeo S, et al. Meta-Analysis of Massage Therapy on Cancer Pain [J]. Integr Cancer Ther, 2015, 14(4): 297-304.
https://doi.org/10.1177/1534735415572885 (In Chinese). |
| [132] | Zhang X, Wang A, Wang M, et al. Non-pharmacological therapy for chemotherapy-induced peripheral neurotoxicity: a network meta-analysis of randomized controlled trials [J]. BMC Neurol, 2023, 23(1): 433. |
| [133] | Corasaniti MT, Bagetta G, Morrone LA, et al. Efficacy of Essential Oils in Relieving Cancer Pain: A Systematic Review and Meta-Analysis [J]. Int J Mol Sci, 2023, 24(8): 7085. |
| [134] | Melesse TG, Chau JPC, Nan MA. Effects of cognitive-behavioural therapy on psychological, physical and social outcomes of children with cancer: A systematic review and meta-analysis [J]. J Psychosom Res, 2022, 157: 110805. |
| [135] | Danon N, Al-Gobari M, Burnand B, et al. Are mind-body therapies effective for relieving cancer-related pain in adults? A systematic review and meta-analysis [J]. Psychooncology, 2022, 31(3): 345-371. |
| [136] | Johannsen M, O'Connor M, O'Toole MS, et al. Efficacy of Mindfulness-Based Cognitive Therapy on Late Post-Treatment Pain in Women Treated for Primary Breast Cancer: A Randomized Controlled Trial [J]. J Clin Oncol, 2016, 34(28): 3390-9. |
| [137] | Ruano A, García-Torres F, Gálvez-Lara M, et al. Psychological and Non-Pharmacologic Treatments for Pain in Cancer Patients: A Systematic Review and Meta-Analysis [J]. J Pain Symptom Manage, 2022, 63(5): e505-e520. |
| [138] | Chang YC, Tseng TA, Lin GM, et al. Immediate impact of Mindfulness-Based Cognitive Therapy (MBCT) among women with breast cancer: a systematic review and meta-analysis [J]. BMC Womens Health, 2023, 23(1): 331. |
| [139] | Lin LY, Lin LH, Tzeng GL, et al. Effects of Mindfulness-Based Therapy for Cancer Patients: A Systematic Review and Meta-analysis [J]. J Clin Psychol Med Settings, 2022, 29(2): 432-445. |
| [140] | Ngamkham S, Holden JE, Smith EL. A Systematic Review: Mindfulness Intervention for Cancer-Related Pain [J]. Asia Pac J Oncol Nurs, 2019, 6(2): 161-169. |
| [141] |
Yang T, Chen JZ, He LS, et al. Meta-analysis of the intervention effect of mindfulness-based stress reduction on cancer pain patients [J]. Nursing Practice and Research, 2022, 19(10): 1529-1534.
https://doi.org/10.3969/j.issn.1672-9676.2022.10.024 (In Chinese). |
| [142] | Sine H, Achbani A, Filali K. The Effect of Hypnosis on the Intensity of Pain and Anxiety in Cancer Patients: A Systematic Review of Controlled Experimental Trials [J]. Cancer Invest, 2022, 40(3): 235-253. |
| [143] | Thuma K, Ditsataporncharoen T, Arunpongpaisal S, et al. Hypnosis as an Adjunct for Managing Pain in Head and Neck Cancer Patients Post Radiotherapy [J]. J Med Assoc Thai, 2016, 99 Suppl 5: S141-7. |
| [144] | Moreno Hernández D, Téllez A, Sánchez-Jáuregui T, et al. Clinical Hypnosis For Pain Reduction In Breast Cancer Mastectomy: A Randomized Clinical Trial [J]. Int J Clin Exp Hypn, 2022, 70(1): 4-15. |
| [145] | De Paolis G, Naccarato A, Cibelli F, et al. The effectiveness of progressive muscle relaxation and interactive guided imagery as a pain-reducing intervention in advanced cancer patients: A multicentre randomised controlled non-pharmacological trial [J]. Complement Ther Clin Pract, 2019, 34: 280-287. |
| [146] | Guo MJ, Xiong Y, Tao SL, et al. Meta-analysis of the effects of music therapy on pain and negative emotions in breast cancer patients [J]. Journal of Mudanjiang Medical University, 2023, 44(5): 100-105. (In Chinese). |
| [147] | Behzadmehr R, Dastyar N, Moghadam MP, et l. Effect of complementary and alternative medicine interventions on cancer related pain among breast cancer patients: A systematic review [J]. Complement Ther Med, 2020, 49: 102318. |
| [148] | Trigueros-Murillo A, Martinez-Calderon J, Casuso-Holgado MJ, et al. Effects of music-based interventions on cancer-related pain, fatigue, and distress: an overview of systematic reviews [J]. Support Care Cancer, 2023, 31(8): 488. |
| [149] | Yangöz ŞT, Özer Z. The effect of music intervention on patients with cancer-related pain: A systematic review and meta-analysis of randomized controlled trials [J]. J Adv Nurs, 2019, 75(12): 3362-3373. |
| [150] | Rennie C, Irvine DS, Huang E, et al. Music Therapy as a Form of Nonpharmacologic Pain Modulation in Patients with Cancer: A Systematic Review of the Current Literature [J]. Cancers (Basel), 2022, 14(18): 4416. |
| [151] | Prinsloo S, Novy D, Driver L, et al. Randomized controlled trial of neurofeedback on chemotherapy-induced peripheral neuropathy: A pilot study [J]. Cancer, 2017, 123(11): 1989-1997. |
| [152] | Prinsloo S, Novy D, Driver L, et al. The Long-Term Impact of Neurofeedback on Symptom Burden and Interference in Patients With Chronic Chemotherapy-Induced Neuropathy: Analysis of a Randomized Controlled Trial [J]. J Pain Symptom Manage, 2018, 55(5): 1276-1285. |
| [153] | Prinsloo S, Kaptchuk TJ, De Ridder D, et al. Brain-computer interface relieves chronic chemotherapy-induced peripheral neuropathy: A randomized, double-blind, placebo-controlled trial [J]. Cancer, 2024, 130(2): 300-311. |
| [154] | Li J, Zhu C, Liu C, et al. Effectiveness of eHealth interventions for cancer-related pain, fatigue, and sleep disorders in cancer survivors: A systematic review and meta-analysis of randomized controlled trials [J]. J Nurs Scholarsh, 2022, 54(2): 184-190. |
| [155] | Buonanno P, Marra A, Iacovazzo C, et al. Telemedicine in Cancer Pain Management: A Systematic Review and Meta-Analysis of Randomized Controlled Trials [J]. Pain Med, 2023, 24(3): 226-233. |
| [156] | Chen W, Huang J, Cui Z, et al. The efficacy of telemedicine for pain management in patients with cancer: a systematic review and meta-analysis [J]. Ther Adv Chronic Dis, 2023, 14: 20406223231153097. |
| [157] | Lopez-Rodriguez MM, Fernández-Millan A, Ruiz-Fernández MD, et al. New Technologies to Improve Pain, Anxiety and Depression in Children and Adolescents with Cancer: A Systematic Review [J]. Int J Environ Res Public Health, 2020, 17(10): 3563. |
| [158] | Simon JDHP, Schepers SA, van Gorp M, et al. Pain monitoring app leads to less pain in children with cancer at home: Results of a randomized controlled trial [J]. Cancer, 2024, 130(13): 2339-2350. |
| [159] | Zheng C, Chen X, Weng L, et al. Benefits of Mobile Apps for Cancer Pain Management: Systematic Review [J]. JMIR Mhealth Uhealth, 2020, 8(1): e17055. |
| [160] | Abahussin AA, West RM, Wong DC, et al. PROMs for Pain in Adult Cancer Patients: A Systematic Review of Measurement Properties [J]. Pain Pract, 2019, 19(1): 93-117. |
| [161] | Weng L, Lin W, Lin X, et al. Randomized controlled trial of an app for cancer pain management [J]. Support Care Cancer, 2024, 32(4): 244. |
| [162] | Cheng Z, Yu S, Zhang W, et al. Virtual reality for pain and anxiety of pediatric oncology patients: A systematic review and meta-analysis [J]. Asia Pac J Oncol Nurs, 2022, 9(12): 100152. |
| [163] | Ozturk CS, Toruner EK. Effectiveness of Virtual Reality in Anxiety and Pain Management in Children and Adolescents Receiving Cancer Treatment: A Systematic Review and Meta-analysis of Randomized Controlled Trials [J]. J Med Syst, 2023, 47(1): 103. |
| [164] | Ahmad M, Bani Mohammad E, Anshasi HA. Virtual Reality Technology for Pain and Anxiety Management among Patients with Cancer: A Systematic Review [J]. Pain Manag Nurs, 2020, 21(6): 601-607. |
| [165] |
Professional Committee of Cancer Rehabilitation and Palliative Care, Chinese Anti-Cancer Association. Expert consensus on patient-controlled analgesia for cancer pain management [J]. Chinese Journal of Clinical Oncology, 2023, 50(15): 757-763.
https://doi.org/10.12354/j.issn.1000-8179.2023.20230486 (In Chinese). |
| [166] | Kizza IB, Muliira JK, Al Jabri KA, et al. Family Caregivers of Adult Cancer Patients in Oman: Predictors of Caregivers' Self-efficacy for Cancer Pain and Related Symptom Management at Home [J]. Cancer Nurs, 2022. |
| [167] | Liu HJ, Li WY, Chen HF, et al. Long-Term Intrathecal Analgesia With a Wireless Analgesia Pump System in the Home Care of Patients With Advanced Cancer [J]. Am J Hosp Palliat Care, 2017, 34(2): 148-153. |
| [168] |
Expert Consensus on Intelligent Patient-Controlled Analgesia Management" Working Group of Chinese Society of Anesthesiology, Chinese Medical Association. Expert consensus on intelligent patient-controlled analgesia management [J]. Chinese Journal of Anesthesiology 2018, 38(10): 1161-1165.
https://doi.org/10.3760/cma.j.issn.0254-1416.2018.10.002 (In Chinese). |
| [169] |
Yu Y, Chen XH, Ma GS, et al. Application of cancer pain management platform in remote analgesia management for home-based cancer pain patients [J]. Chinese Journal of Painology,, 2022, 18(5): 651-655.
https://doi.org/10.3760/cma.j.cn101658-20220525-00084 (In Chinese). |
| [170] | Duarte R, Copley S, Nevitt S, et al. Effectiveness and Safety of Intrathecal Drug Delivery Systems for the Management of Cancer Pain: A Systematic Review and Meta-Analysis [J]. Neuromodulation, 2023, 26(6): 1126-1141. |
| [171] |
Feng ZY, Wang K, Jin Y, et al. Chinese expert consensus on intrathecal drug delivery systems for cancer pain management (2022 version) [J]. Chinese Journal of Painology, 2022, 18(5): 579-589.
https://doi.org/10.3760/cma.j.cn101658-20220208-00140 (In Chinese). |
| [172] |
Cancer Pain and Palliative Care Expert Group of Pain Physician Branch, Chinese Medical Doctor Association; Cancer Pain Group of Pain Medicine Branch, Chinese Medical Association. Chinese expert consensus on patient-controlled intravenous analgesia for cancer pain patients [J]. National Medical Journal of China, 2023, 103(11): 793-802.
https://doi.org/10.3760/cma.j.cn112137-20221105-02319 (In Chinese). |
| [173] | Lin R, Lin S, Feng S, et al. Comparing Patient-Controlled Analgesia Versus Non-PCA Hydromorphone Titration for Severe Cancer Pain: A Randomized Phase III Trial [J]. J Natl Compr Canc Netw, 2021, 19(10): 1148-1155. |
| [174] | Nijland L, Schmidt P, Frosch M, et al. Subcutaneous or intravenous opioid administration by patient-controlled analgesia in cancer pain: a systematic literature review [J]. Support Care Cancer, 2019, 27(1): 33-42. |
| [175] |
Liu XL, Wan CF, Ma K, et al. Chinese expert consensus on continuous subcutaneous infusion for cancer pain management (2020 version) [J]. Chinese Journal of Painology, 2020, 16(2): 85-91.
https://doi.org/10.3760/cma.j.cn101658-20200410-2004-099 (In Chinese). |
| [176] | Wan CF, Meng QZ, Wang YW, et al. Patient-controlled subcutaneous analgesia using sufentainil or morphine in home care treatment in patients with stage III-IV cancer: A multi-center randomized controlled clinical trial [J]. Cancer Med, 2020, 9(15): 5345-5352. |
| [177] | He QH, Liu QL, Li Z, et al. Impact of epidural analgesia on quality of life and pain in advanced cancer patients [J]. Pain Manag Nurs, 2015, 16(3): 307-13. |
| [178] | Hsieh YL, Chen HY, Lin CR, et al. Efficacy of epidural analgesia for intractable cancer pain: A systematic review [J]. Pain Pract, 2023, 23(8): 956-969. |
| [179] | Kong FL, Bie ZX, Li B, et al. Comparison of analgesic effect in celiac plexus neurolysis: ethanol injection with or without iodine 125 radioactive seeds implantation [J]. J Cancer Res Ther, 2022, 18(5): 1306-1311. |
| [180] | Reyad RM, Hakim SM, Abbas DN, et al. A novel technique of saddle rhizotomy using thermal radiofrequency for intractable perineal pain in pelvic malignancy: a pilot study [J]. Pain Physician, 2018, 21(6): E651-E660. |
| [181] | Matsumoto T, Yoshimatsu R, Osaki M, et al. Percutaneous splanchnic nerve neurolysis analgesic efficacy and safety for cancer-related pain: a systematic review and meta-analysis [J]. Support Care Cancer, 2023, 31(6): 324. |
| [182] | Koulouris AI, Alexandre L, Hart AR, et al. Endoscopic ultrasound-guided celiac plexus neurolysis (EUS-CPN) technique and analgesic efficacy in patients with pancreatic cancer: A systematic review and meta-analysis [J]. Pancreatology, 2021, 21(2): 434-442. |
| [183] | Pacheco-Feijoó GM, Amado-Tineo JP, Plancarte-Sánchez R, et al. Efficacy and Safety of Celiac Plexus Neurolysis in the Treatment of Chronic Pain Secondary to Oncological Pathology of the Upper Hemiabdomen: A Systematic Review and Meta-Analysis [J]. Indian J Palliat Care, 2023, 29(4): 394-406. |
| [184] | Asif AA, Walayat SK, Bechtold ML, et al. EUS-guided celiac plexus neurolysis for pain in pancreatic cancer patients - a meta-analysis and systematic review [J]. J Community Hosp Intern Med Perspect, 2021, 11(4): 536-542. |
| [185] | Okita M, Otani K, Gibo N, et al. Systematic review and meta-analysis of celiac plexus neurolysis for abdominal pain associated with unresectable pancreatic cancer [J]. Pain Pract, 2022, 22(7): 652-661. |
| [186] | Bang JY, Sutton B, Hawes RH, et al. EUS-guided celiac ganglion radiofrequency ablation versus celiac plexus neurolysis for palliation of pain in pancreatic cancer: a randomized controlled trial (with videos) [J]. Gastrointest Endosc, 2019, 89(1): 58-66. e3. |
| [187] | Matsumoto T, Yoshimatsu R, Osaki M, et al. Analgesic efficacy and safety of percutaneous thermal ablation plus cementoplasty for painful bone metastases: a systematic review and meta-analysis [J]. Int J Clin Oncol, 2024, 29(4): 372-385. |
| [188] | Murali N, Turmezei T, Bhatti S, et al. What is the effectiveness of radiofrequency ablation in the management of patients with spinal metastases? A systematic review and meta-analysis [J]. J Orthop Surg Res, 2021, 16(1): 659. |
| [189] | Ravikanth R. Management of metastatic vertebral lesions by interventional techniques: Systematic review of outcomes [J]. J Craniovertebr Junction Spine, 2020, 11(2): 61-70. |
| [190] | Piras A, La Vecchia M, Boldrini L, et al. Radiofrequency thermoablation (RFA) and radiotherapy (RT) combined treatment for bone metastases: a systematic review [J]. Eur Rev Med Pharmacol Sci, 2021, 25(10): 3647-3654. |
| [191] | Gennaro N, Sconfienza LM, Ambrogi F, et al. Thermal ablation to relieve pain from metastatic bone disease: a systematic review [J]. Skeletal Radiol, 2019, 48(8): 1161-1169. |
| [192] | Yao PF, Hu A, Mansour F, et al. Image Guided Energy blation for Palliation of Painful Bony Metastases - A Systematic Review [J]. J Vasc Interv Radiol, 2024, S1051-0443(24)00374-9. |
| [193] | Vachirakorntong B, Kawana E, Zhitny VP, et al. Radiofrequency Ablation's Effectiveness for Treating Abdominal and Thoracic Chronic Pain Syndromes: A Systematic Review of the Current Literature [J]. Pain Physician, 2023, 26(7): E737-E759. |
| [194] | Abbas DN, Reyad RM. Thermal Versus Super Voltage Pulsed Radiofrequency of Stellate Ganglion in Post-Mastectomy Neuropathic Pain Syndrome: A Prospective Randomized Trial [J]. Pain Physician, 2018, 21(4): 351-362. |
| [195] | Amr SA, Reyad RM, Othman AH, et al. Comparison between radiofrequency ablation and chemical neurolysis of thoracic splanchnic nerves for the management of abdominal cancer pain, randomized trial [J]. Eur J Pain, 2018, 22(10): 1782-1790. |
| [196] | Khanmohammadi S, Noroozi A, Yekaninejad MS, et al. Cryoablation for the Palliation of Painful Bone Metastasis: A Systematic Review [J]. Cardiovasc Intervent Radiol, 2023, 46(11): 1469-1482. |
| [197] | Ferrer-Mileo L, Luque Blanco AI, González-Barboteo J. Efficacy of Cryoablation to Control Cancer Pain: A Systematic Review [J]. Pain Pract, 2018, 18(8): 1083-1098. |
| [198] | Health Quality Ontario. Vertebral Augmentation Involving Vertebroplasty or Kyphoplasty for Cancer-Related Vertebral Compression Fractures: A Systematic Review [J]. Ont Health Technol Assess Ser, 2016, 16(11): 1-202. |
| [199] | Sørensen ST, Kirkegaard AO, Carreon L, et al. Vertebroplasty or kyphoplasty as palliative treatment for cancer-related vertebral compression fractures: a systematic review [J]. Spine J, 2019, 19(6): 1067-1075. |
| [200] | Mattie R, Brar N, Tram JT, et al. Vertebral Augmentation of Cancer-Related Spinal Compression Fractures: A Systematic Review and Meta-Analysis [J]. Spine (Phila Pa 1976), 2021, 46(24): 1729-1737. |
| [201] | Han Q, Deng M, Lv Y, et al. Survival of patients with advanced pancreatic cancer after iodine125 seeds implantation brachytherapy: A meta-analysis [J]. Medicine (Baltimore), 2017, 96(5): e5719. |
| [202] | Perruchoud C, Dupoiron D, Papi B, et al. Management of Cancer-Related Pain With Intrathecal Drug Delivery: A Systematic Review and Meta-Analysis of Clinical Studies [J]. Neuromodulation, 2023, 26(6): 1142-1152. |
| [203] | Kenfield M, Zacharias N, Abd-Elsayed A. Intrathecal Drug Delivery for the Treatment of Cancer-Associated Chronic Pain in Children [J]. Neuromodulation, 2023, 26(6): 1153-1163. |
| [204] | L'Hotta AJ, Randolph SB, Reader B, et al. Clinical practice guideline and expert consensus recommendations for rehabilitation among children with cancer: A systematic review [J]. CA Cancer J Clin, 2023, 73(5): 524-545. |
| [205] |
Refractory Cancer Pain Group of Professional Committee of Cancer Rehabilitation and Palliative Care, Chinese Anti-Cancer Association; Cancer Pain Group of Pain Medicine Branch, Chinese Medical Association. Expert consensus on cancer-related breakthrough pain (2019 version) [J]. Chinese Journal of Clinical Oncology, 2019, 46(6): 267-271.
https://doi.org/10.3969/j.issn.1000-8179.2019.06.228 (In Chinese). |
| [206] | Brant JM, Rodgers BB, Gallagher E, et al. Breakthrough Cancer Pain: A Systematic Review of Pharmacologic Management. Clin J Oncol Nurs, 2017, 21(3 Suppl): 71-80. |
| [207] | Hashemi M, Zali A, Golmakani E, et al. Efficacy, safety, and tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain: a randomized, double-blind, placebo-controlled study. Daru, 2021, 29(1): 51-59. |
| [208] | Yousef AA, Alzeftawy AE. The efficacy of oral piroxicam fast-dissolving tablets versus sublingual fentanyl in incident breakthrough pain due to bone metastases: a double-blinded randomized study. Support Care Cancer, 2019, 27(6): 2171-2177. |
| [209] | Alberts DS, Smith CC, Parikh N, et al. Fentanyl sublingual spray for breakthrough cancer pain in patients receiving transdermal fentanyl. Pain Manag, 2016, 6(5): 427-34. |
| [210] | Thronæs M, Popper L, Eeg M, et al. Efficacy and tolerability of intranasal fentanyl spray in cancer patients with breakthrough pain. Clin Ther, 2015, 37(3): 585-96. |
APA Style
Zhixiang, C., Ke, M., Jianxiu, W., Dequan, W., Cunwei, S., et al. (2025). A Chinese Guideline for the Diagnosis and Treatment of Chronic Cancer-related Pain. International Journal of Pain Research, 1(1), 10-33. https://doi.org/10.11648/j.ijpr.20250101.12
ACS Style
Zhixiang, C.; Ke, M.; Jianxiu, W.; Dequan, W.; Cunwei, S., et al. A Chinese Guideline for the Diagnosis and Treatment of Chronic Cancer-related Pain. . 2025, 1(1), 10-33. doi: 10.11648/j.ijpr.20250101.12
AMA Style
Zhixiang C, Ke M, Jianxiu W, Dequan W, Cunwei S, et al. A Chinese Guideline for the Diagnosis and Treatment of Chronic Cancer-related Pain. . 2025;1(1):10-33. doi: 10.11648/j.ijpr.20250101.12
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ijpr.20250101.12,
author = {Cheng Zhixiang and Ma Ke and Wang Jianxiu and Wang Dequan and Shi Cunwei and Liu Jinfeng and Liu Haipeng and Song Tao and Zhang Baojuan and Lin Xuewu and Zhou Huacheng and Wan Chunfu and Cao Hanzhong and Shu Ya and Fan Xiaochong and Liu Yanqing},
title = {A Chinese Guideline for the Diagnosis and Treatment of Chronic Cancer-related Pain
},
journal = {International Journal of Pain Research},
volume = {1},
number = {1},
pages = {10-33},
doi = {10.11648/j.ijpr.20250101.12},
url = {https://doi.org/10.11648/j.ijpr.20250101.12},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijpr.20250101.12},
abstract = {Background: Chronic cancer-related pain can seriously damage physical and mental health of cancer patients. Eliminating cancer pain is basic right of cancer patients, controlling and eliminating cancer pain is the responsibility of medical staff. Objective: To further enhance the diagnosis and treatment capabilities for chronic cancer-related pain management, the Chinese Clinical Guideline for Chronic Cancer-Related Pain convened an expert panel to develop the guideline. Main ideas: Based on high quality evidence of medical researches on the diagnosis and treatment of chronic cancer-related pain published domestically and internationally in the past 10 years, the expert group has formed recommendations for common treatment methods through rigorous argumentation and expert voting, to provide references for standardized diagnosis and treatment of chronic cancer-related pain. This guideline adopts GRADE methodology to evaluate the level of evidence and strength of recommendation for the treatments of chronic cancer-related pain. This guideline gives treatment recommendations for different types of chronic cancer-related pain in International Classification of Diseases-11, as well as for breakthrough cancer pain. Conclusion: Although there are many treatments to relieve chronic cancer-related pain, it is still a global medical challenge. According to the characteristics of cancer-related pain, stepped and personalized treatment is the key to relieve pain.},
year = {2025}
}
TY - JOUR T1 - A Chinese Guideline for the Diagnosis and Treatment of Chronic Cancer-related Pain AU - Cheng Zhixiang AU - Ma Ke AU - Wang Jianxiu AU - Wang Dequan AU - Shi Cunwei AU - Liu Jinfeng AU - Liu Haipeng AU - Song Tao AU - Zhang Baojuan AU - Lin Xuewu AU - Zhou Huacheng AU - Wan Chunfu AU - Cao Hanzhong AU - Shu Ya AU - Fan Xiaochong AU - Liu Yanqing Y1 - 2025/07/28 PY - 2025 N1 - https://doi.org/10.11648/j.ijpr.20250101.12 DO - 10.11648/j.ijpr.20250101.12 T2 - International Journal of Pain Research JF - International Journal of Pain Research JO - International Journal of Pain Research SP - 10 EP - 33 PB - Science Publishing Group UR - https://doi.org/10.11648/j.ijpr.20250101.12 AB - Background: Chronic cancer-related pain can seriously damage physical and mental health of cancer patients. Eliminating cancer pain is basic right of cancer patients, controlling and eliminating cancer pain is the responsibility of medical staff. Objective: To further enhance the diagnosis and treatment capabilities for chronic cancer-related pain management, the Chinese Clinical Guideline for Chronic Cancer-Related Pain convened an expert panel to develop the guideline. Main ideas: Based on high quality evidence of medical researches on the diagnosis and treatment of chronic cancer-related pain published domestically and internationally in the past 10 years, the expert group has formed recommendations for common treatment methods through rigorous argumentation and expert voting, to provide references for standardized diagnosis and treatment of chronic cancer-related pain. This guideline adopts GRADE methodology to evaluate the level of evidence and strength of recommendation for the treatments of chronic cancer-related pain. This guideline gives treatment recommendations for different types of chronic cancer-related pain in International Classification of Diseases-11, as well as for breakthrough cancer pain. Conclusion: Although there are many treatments to relieve chronic cancer-related pain, it is still a global medical challenge. According to the characteristics of cancer-related pain, stepped and personalized treatment is the key to relieve pain. VL - 1 IS - 1 ER -
Department of Painology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China
Department of Painology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
Department of Painology, Zibo Central Hospital, Zibo, China
Department of Painology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China
Department of Painology, Qinghai University Affiliated Hospital, Xining, China
Department of Painology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
Department of Painology, Gansu Provincial Hospital, Lanzhou, China
Departmentof Painology, The First Hospital of China Medical University, Shenyang, China
Departmentof Painology, The First People's Hospital of Jining City, Jining, China
Department of Painology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China
Department of Painology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China
Department of Painology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China
Department of Painology, Nantong Tumor Hospital, Nantong University, Nantong, China
Department of Painology, The First Affiliated Hospital of Xi'an Medical University, Xi'an, China
Department of Painology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
Department of Painology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
Information